Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Abstract The Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma
proposed by the Japan Society of Hepatology was updated in June 2014 at a consensus …

The 3rd version of C linical P ractice G uidelines for H epatocellular C arcinoma was revised
by the J apan S ociety of H epatology, according to the methodology of evidence‐based …

Objective: To compare microvascular invasion (McVI) with parameters defined by the Milan
criteria in predicting tumor recurrence and overall survival (OS) in patients with surgical …

This review outlines the significance of establishing general rules, a nationwide follow-up
survey, and clinical practice guidelines for liver cancer in Japan. The general rules are an …

Abstract Alpha-fetoprotein (AFP), Lens culinaris-agglutinin-reactive fraction of AFP (AFP-L3),
and protein induced by vitamin K absence or antagonist-II (PIVKA-II) are widely used as …

Indocyanine green (ICG) kinetics (PDR/R15) used to quantitatively assess hepatic function
in the perioperative period of major resective surgery and liver transplantation have been …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Hepatocellular carcinoma (HCC) represents the fifth most common cancer in the world, and
the third most frequent oncological cause of death. The incidence of HCC is on the increase …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …